This topic contains a solution. Click here to go to the answer

Author Question: A patient with a head injury should not receive a narcotic agonist for which reason? a. The ... (Read 82 times)

roselinechinyere27m

  • Hero Member
  • *****
  • Posts: 557
A patient with a head injury should not receive a narcotic agonist for which reason?
 
  a. The patient will not be able to talk.
  b. The drug makes the patient too hyperactive.
  c. Addiction is easy at this point.
  d. The drug causes a confusing effect.

Question 2

Long-term use of dopaminergic drugs often leads to which condition?
 
  a. Muscle flaccidity
  b. Migraine headaches
  c. Incontinence
  d. Tardive dyskinesia



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tmlewis4706

  • Sr. Member
  • ****
  • Posts: 295
Answer to Question 1

ANS: D
The nurse must be able to monitor the patient without the confusing effect of a narcotic agonist.

Answer to Question 2

ANS: D
The long-term use of dopaminergic drugs can cause tardive dyskinesia.




roselinechinyere27m

  • Member
  • Posts: 557
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


Kedrick2014

  • Member
  • Posts: 359
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library